The first EU-wide STAR treatment registry is now open! STOPSTORM is now accepting data from our 30 partner organizations across 8 European countries. Later, we will expand this to even more centers across the EU. STOPSTORM aims to collect data from over 300 patients into the registry by 2025. This data will help to establish the indication, safety, and efficacy of STAR for the treatment for ventricular tachycardia.
What is STAR treatment? STAR is a non-invasive radiotherapy technique used to treat dangerously fast heart rhythm, called ventricular tachycardia or VT. A similar radiotherapy technique has been used for a decade to treat lung cancer. Application of STAR for use in VT is relatively new, and while early results are promising, there is still more to learn about the longer-term effects of this treatment. Therefore, STOPSTORM has created an EU-wide database to better understand the safety and efficacy of the treatment.
Learn more about the STAR treatment in our animation, which is available in 9 different languages:
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 945119.